
About H.I.G. BioHealth
We invest in companies developing novel products for significant unmet medical needs, primarily in the following sectors:
- Therapeutics (small molecules, protein therapeutics, antibodies, etc.)
- Medical devices
- Diagnostics
After making an investment, the H.I.G. BioHealth Partners team works closely with portfolio companies in key areas, including:
- Pre-clinical and clinical development strategy
- Management recruitment
- Business development activities
- Follow on equity and debt financing
- Achieving liquidity through M&A or IPO